By Michele Maatouk
Date: Monday 03 Aug 2026
(Sharecast News) - AstraZeneca is reportedly in talks to combine with US rival Bristol Myers Squibb in a deal that would create one of the world's biggest pharmaceutical groups, valued at nearly $400bn.
| Deutsche Bank cuts Rentokil target price | 03-Aug-2026 | ShareCast |
| RBC lowers JD Sports to 'sector perform' | 03-Aug-2026 | ShareCast |
| F&C hails AI investments as chair Holland steps ... | 03-Aug-2026 | ShareCast |
| TotalEnergies to buy Shell's European onshore re... | 03-Aug-2026 | ShareCast |
| National Grid streamlines leadership structure | 03-Aug-2026 | ShareCast |
| Form 8.5 (EPT/RI)-Replacement of SEGRO plc | 03-Aug-2026 | 18:29 | RNS |
| Transaction in Own Shares | 03-Aug-2026 | 18:15 | RNS |
| Total Voting Rights | 03-Aug-2026 | 18:15 | RNS |
| Director/PDMR Shareholding | 03-Aug-2026 | 18:15 | RNS |
| Admission to Trading | 03-Aug-2026 | 18:15 | RNS |
| Questor:Meggitt | 23-Dec-2014 | Telegraph |
| Questor:Babcock | 19-Dec-2014 | Telegraph |
| Questor :Aberdeen Asset Management | 03-Dec-2014 | Telegraph |
| Questor :Petrofac | 26-Nov-2014 | Telegraph |
| Questor :Royal Mail | 21-Nov-2014 | Telegraph |
| Price | 10,857.70 |
| Change Today | -10.35 |
| % Change | -0.10 % |
| 31-Jul-26 Close | 10,868.05 |
You are here: research